ND02 is under clinical development by HK inno.N and currently in Phase II for Glaucoma. According to GlobalData, Phase II drugs for Glaucoma have a 39% phase transition success rate (PTSR) indication ...

PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next generation ...

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...

The S&P 500's returns are measured using time-weighted returns (TWR), which don't account for cash flows like withdrawals. If you're retired and withdrawing funds, comparing your portfolio to the S&P ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

With hydrocarbon demand showing few signs of peaking and shareholder activism waning, oil companies will likely invest more in the upstream and LNG.

As with any technological advancement, there are problems with current artificial intelligence systems. According to VERSES ...